AI Insight
A small clinical trial investigated whether a postbiotic supplement containing dead bacteria could stimulate the body's natural production of GLP-1, a hormone that regulates appetite and blood sugar. The supplement showed potential as a weight-loss aid by boosting endogenous GLP-1 levels, which could offer a more affordable alternative to injectable GLP-1 receptor agonist medications like semaglutide. However, the study was limited in size and requires larger, more rigorous trials to confirm efficacy and safety.
Why it matters
If validated in larger studies, this approach could provide a more accessible and cost-effective weight-loss intervention compared to expensive pharmaceutical GLP-1 drugs. The use of postbiotics to stimulate natural hormone production represents a potentially innovative strategy in obesity treatment that could reach broader populations.
Understand the Science
A small trial suggests a supplement containing dead bacteria could offer a cheaper alternative to weight-loss drugs such as semaglutide, but further evidence is needed
Source: Postbiotic supplement boosts body’s own GLP-1 and weight loss